Perioperative Fruquintinib Combined With Sintilimab and SOX for Locally Advanced Gastric or GEJ Adenocarcinoma

NCT07658872 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Gastric Adenocarcinoma
Esophagogastric Junction Adenocarcinoma

Interventions

DRUG: fruquintinib + sintilimab + SOX
DRUG: Sinitilimab+SOX

Sponsor

Sichuan University